Literature DB >> 9311010

Expression of bcl-6 protein in normal skin and epidermal neoplasms.

N Kanazawa1, M Moriyama, T Onizuka, K Sugawara, S Mori.   

Abstract

Bcl-6 protein is a recently identified novel transcription factor whose deregulated expression is associated with diffuse large B cell lymphomas. It was recently shown by us that the protein is located in germinal center B cells and their neoplastic counterparts. In the present study, the expression of bcl-6 protein on normal epidermis, benign, and malignant tumors originating from epidermal cells, and squamous cell carcinoma (SCC) cell lines are investigated. With the use of immunohistochemistry, bcl-6 protein was shown to stain intensely on normal prickle cells, but none to only slightly on epidermal basal cells. Papillomas and keratoacanthomas copied their normal counterparts in the mode of expression. Various levels of expression were found on seborrheic keratoses, while the expression level on basal cell epitheliomas was low. Peculiarly, eccrine poromas and undifferentiated spindle-shaped basal cell epitheliomas were totally unstained. Squamous cell carcinomas showed a variety of expression levels, while two undifferentiated spindle-shaped carcinomas and one undifferentiated SCC cell line remained unstained. These results suggest that the expression of bcl-6 protein may be associated with morphological differentiation in normal and neoplastic epidermal cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311010     DOI: 10.1111/j.1440-1827.1997.tb04548.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

1.  Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.

Authors:  Anshu Aggarwal; William J Hunter; Himanshu Aggarwal; Edibaldo D Silva; Mary S Davey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-21       Impact factor: 3.362

2.  Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome.

Authors:  Aghiad Chamdin; Jason A Jarzembowski; Chitra Subramanian; Rork Kuick; Julia Shin-Jung Lee; Roland Ps Kwok; Valerie P Castle; Anthony W Opipari
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

3.  The expression of bcl-2 and bcl-6 protein in normal and malignant transitional epithelium.

Authors:  Zhenhua Lin; Hankyeom Kim; Hongseok Park; Youngsik Kim; Jun Cheon; Insun Kim
Journal:  Urol Res       Date:  2003-07-16

4.  Rac1 signaling modulates BCL-6-mediated repression of gene transcription.

Authors:  Patrícia Barros; Peter Jordan; Paulo Matos
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

5.  Rac1 signalling modulates a STAT5/BCL-6 transcriptional switch on cell-cycle-associated target gene promoters.

Authors:  Patrícia Barros; Eric W-F Lam; Peter Jordan; Paulo Matos
Journal:  Nucleic Acids Res       Date:  2012-06-20       Impact factor: 16.971

6.  BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma.

Authors:  Peir-In Liang; Chien-Feng Li; Li-Tzong Chen; Ding-Ping Sun; Tzu-Ju Chen; Chung-Hsi Hsing; Han-Ping Hsu; Ching-Yih Lin
Journal:  Tumour Biol       Date:  2013-10-11

7.  B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells.

Authors:  Qiang Wu; Xue Liu; Hong Yan; Yin-huan He; Shan Ye; Xing-wang Cheng; Gui-lu Zhu; Wen-yong Wu; Xiao-nan Wang; Xiang-jun Kong; Xiao-chun Xu; Peter E Lobie; Tao Zhu; Zheng-Sheng Wu
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

8.  Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.

Authors:  Wen-Ren Wu; Jen-Tai Lin; Cheng-Tang Pan; Ti-Chun Chan; Chen-Liang Liu; Wen-Jeng Wu; Jim Jinn-Chyuan Sheu; Bi-Wen Yeh; Steven K Huang; Jheng-Yan Jhung; Meng-Shin Hsiao; Chien-Feng Li; Yow-Ling Shiue
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.